Judd Moul, MD, explains why he disagrees with the recent move by the US Preventive Services Task Force to give the routine PSA exam a D-rating. He discusses…
When should patients seek a biopsy on their prostate? Under what circumstances is a biopsy administered? Stacy Loeb, MD, explains that the American Urological Association’s 2009 guidelines, the PSA,…
Recent Videos in Advances in Prostate Cancer Treatment
Stacy Loeb, MD discusses how the decision for prostate cancer screening should be an individual one, rather than population-based. Individual risk factors including age, general health, family history,…
With the continual advancement of technology in surgery, one would expect that robotic prostatectomy to be the gold standard of treatment for prostate cancer. However, Judd Moul, MD,…
Janna Andrews, MD takes us for a tour of the latest technological advancements in the field of radiation therapy delivery for prostate cancer treatment. She explains the benefits…
Low-risk prostate cancer patients have multiple options when it comes to treatment. Janna Andrews, MD, characterizes the differences between surgical and radiation treatments as well as the various subcategories…
Janna Andrews, MD, discusses the clinical threshold for when a physician should consider preforming a biopsy after preforming a PSA exam to screen for prostate cancer. She also…
How has the nature of chemotherapy and prostate cancer evolved? Janna Andrews, MD, explains that historically, there were not many options for patients who became resistant to androgen deprivation therapy…
How can physicians evaluate what rising PSA levels mean when screening for prostate cancer? Janna Andrews, MD, explains how PSA levels rise naturally with growing age, and how physicians can use…
